Pluri Inc. Market Cap ($15.23 Million)
Market Cap & Net Worth: Pluri Inc. (PLUR)
Pluri Inc. market cap. Pluri Inc. (NASDAQ:PLUR) has a market capitalization of $15.23 Million ($15.23 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #25784 globally and #5432 in its home market, demonstrating a 13.39% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pluri Inc.'s stock price $1.27 by its total outstanding shares 11989546 (11.99 Million). Also see Pluri Inc. (PLUR) cash flow conversion for how efficiently the company converts equity into cash flow.
Pluri Inc. Market Cap History (2015–2026)
Pluri Inc. market cap history from 2015 to 2026. Data shows change from $1.08 Billion to $15.23 Million (-34.73% CAGR). Check latest Pluri Inc. stock price today for real-time trading data and today's change.
Index Memberships
Pluri Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #717 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #2358 of 3165 |
Weight: Pluri Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Pluri Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pluri Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Pluri Inc. (PLUR) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
26.83x
Pluri Inc.'s market cap is 26.83 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.37 Billion | $2.85 Million | -$23.25 Million | 481.77x | N/A |
| 2018 | $755.92 Million | $50.00K | -$26.13 Million | 15118.34x | N/A |
| 2019 | $377.91 Million | $54.00K | -$35.31 Million | 6998.34x | N/A |
| 2020 | $678.13 Million | $23.00K | -$29.15 Million | 29483.86x | N/A |
| 2022 | $90.17 Million | $234.00K | -$41.24 Million | 385.35x | N/A |
| 2023 | $55.58 Million | $287.00K | -$28.32 Million | 193.67x | N/A |
| 2024 | $51.26 Million | $326.00K | -$20.89 Million | 157.22x | N/A |
| 2025 | $35.85 Million | $1.34 Million | -$22.58 Million | 26.83x | N/A |
Competitor Companies of PLUR by Market Capitalization
Companies near Pluri Inc. in the global market cap rankings as of November 4, 2026. Also see Pluri Inc. balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Pluri Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Pluri Inc. (2015–2026)
Market capitalization of Pluri Inc. from 2015 to today. Between 2015 and today, Pluri Inc.'s market cap moved from $1.08 Billion to $ 15.23 Million, with a yearly change of -34.73%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $15.23 Million | -57.53% |
| 2025 | $35.85 Million | -30.06% |
| 2024 | $51.26 Million | -7.79% |
| 2023 | $55.58 Million | -38.36% |
| 2022 | $90.17 Million | -35.61% |
| 2021 | $140.04 Million | -79.35% |
| 2020 | $678.13 Million | +79.44% |
| 2019 | $377.91 Million | -50.01% |
| 2018 | $755.92 Million | -42.89% |
| 2017 | $1.32 Billion | -3.50% |
| 2016 | $1.37 Billion | +26.55% |
| 2015 | $1.08 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Pluri Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.23 Million USD |
| MoneyControl | $15.23 Million USD |
| MarketWatch | $15.23 Million USD |
| marketcap.company | $15.23 Million USD |
| Reuters | $15.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pluri Inc.
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. The company develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. Its product candidates include PLX-PAD, … Read more